Literature DB >> 1438380

The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders.

D S Millington1, N Terada, D H Chace, Y T Chen, J H Ding, N Kodo, C R Roe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1438380

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  15 in total

Review 1.  Genetic hypoglycaemia in infancy and childhood: pathophysiology and diagnosis.

Authors:  J M Saudubray; P de Lonlay; G Touati; D Martin; M C Nassogne; P Castelnau; C Sevin; C Laborde; C Baussan; M Brivet; A Vassault; D Rabier; J P Bonnefont; P Kamoun
Journal:  J Inherit Metab Dis       Date:  2000-05       Impact factor: 4.982

2.  Newborn screening healthcare information system based on service-oriented architecture.

Authors:  Sung-Huai Hsieh; Sheau-Ling Hsieh; Yin-Hsiu Chien; Yung-Ching Weng; Kai-Ping Hsu; Chi-Huang Chen; Chien-Ming Tu; Zhenyu Wang; Feipei Lai
Journal:  J Med Syst       Date:  2009-03-24       Impact factor: 4.460

3.  The effects of aerobic interval training on the left ventricular morphology and function of VLCAD-deficient mice.

Authors:  Charles E Riggs; Marcos A Michaelides; Koulla M Parpa; Nancy J Smith-Blair
Journal:  Eur J Appl Physiol       Date:  2010-07-17       Impact factor: 3.078

4.  Isoprenylcysteine carboxylmethyltransferase regulates mitochondrial respiration and cancer cell metabolism.

Authors:  J T Teh; W L Zhu; O R Ilkayeva; Y Li; J Gooding; P J Casey; S A Summers; C B Newgard; M Wang
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

5.  Diagnosis of inborn errors of metabolism by acylcarnitine profiling in blood using tandem mass spectrometry.

Authors:  C Vianey-Saban; N Guffon; F Delolne; P Guibaud; M Mathieu; P Divry
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

Review 6.  Defects in activation and transport of fatty acids.

Authors:  M Brivet; A Boutron; A Slama; C Costa; L Thuillier; F Demaugre; D Rabier; J M Saudubray; J P Bonnefont
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

7.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

8.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Evaluation of 3-methylcrotonyl-CoA carboxylase deficiency detected by tandem mass spectrometry newborn screening.

Authors:  D D Koeberl; D S Millington; W E Smith; S D Weavil; J Muenzer; S E McCandless; P S Kishnani; M T McDonald; S Chaing; A Boney; E Moore; D M Frazier
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  3-Hydroxyisovalerylcarnitine in 3-methylcrotonyl-CoA carboxylase deficiency.

Authors:  J L van Hove; S L Rutledge; M A Nada; S G Kahler; D S Millington
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.